Physician profile
Jason S Bailey
NPI 1851471486
$369,424.88
in general payments reported to CMS, 2019-2025
23 companies · $162K in 2025
The $162K reported for 2025 was more than what 99% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $14K · 2021: $34K · 2022: $69K · 2023: $61K · 2024: $29K · 2025: $162K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $189K · Travel and Lodging: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $189,061.33 |
| Travel and Lodging | $26,449.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,500.00 |
| Food and Beverage | $14,833.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $361,982.91 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Axonics, INC. | $4,423.79 | 2021-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $860.90 | 2022-2025 | Interstim, Protack, Progrip |
| Boston Scientific Corporation | $688.96 | 2019-2025 | Axonics, Bulkamid, Solyx Sis System |
| Medtronic USA, INC. | $519.61 | 2019-2020 | |
| Smith+Nephew, INC. | $149.67 | 2019-2025 | Grafix Pl, Stravix |
| Abbvie INC. | $130.06 | 2019-2024 | |
| Caldera Medical, INC | $94.72 | 2021 | |
| Mayne Pharma Commercial LLC | $90.77 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $86.97 | 2024-2025 | |
| Daiichi Sankyo INC. | $71.75 | 2019-2022 | |
| Depuy Synthes Sales INC. | $55.78 | 2023-2024 | Matrixmandible |
| Coopersurgical, INC. | $51.55 | 2019-2023 | Advincula Delineator Uterine Manipulator |
| Escala Medical INC. | $42.22 | 2024 | |
| Sumitomo Pharma America, INC. | $28.23 | 2023-2024 | Myfembree |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $27.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.32 | 2019 | |
| Convatec INC. | $22.58 | 2023 | |
| Roche Diagnostics Corporation | $16.49 | 2019 | |
| Innovation Technologies INC | $16.13 | 2024 | Irrisept |
| Mimedx Group, INC. | $14.74 | 2024 | |
| Allergan, INC. | $12.73 | 2019 | |
| Laborie Medical Technologies Corp. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.